News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
302,368 Results
Type
Article (14667)
Company Profile (103)
Press Release (287598)
Multimedia
Podcasts (52)
Webinars (12)
Section
Business (97473)
Career Advice (472)
Deals (17454)
Drug Delivery (67)
Drug Development (39956)
Employer Resources (49)
FDA (7098)
Job Trends (6572)
News (166347)
Policy (15515)
Tag
Academia (502)
Accelerated approval (4)
Adcomms (6)
Allergies (44)
Alliances (26756)
ALS (47)
Alzheimer's disease (484)
Antibody-drug conjugate (ADC) (60)
Approvals (7166)
Artificial intelligence (144)
Autoimmune disease (10)
Automation (6)
Bankruptcy (152)
Best Places to Work (4668)
BIOSECURE Act (9)
Biosimilars (77)
Biotechnology (42)
Bladder cancer (33)
Brain cancer (22)
Breast cancer (124)
Cancer (992)
Cardiovascular disease (90)
Career advice (416)
Career pathing (12)
CAR-T (36)
CDC (3)
Cell therapy (132)
Cervical cancer (5)
Clinical research (34044)
Collaboration (492)
Compensation (209)
Complete response letters (19)
COVID-19 (873)
CRISPR (28)
C-suite (189)
Cystic fibrosis (49)
Data (1073)
Denatured (16)
Depression (21)
Diabetes (108)
Diagnostics (1807)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (73)
Drug pricing (80)
Drug shortages (12)
Duchenne muscular dystrophy (65)
Earnings (36205)
Editorial (14)
Employer branding (4)
Employer resources (44)
Events (42004)
Executive appointments (486)
FDA (7792)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (330)
Gene editing (48)
Generative AI (9)
Gene therapy (131)
GLP-1 (397)
Government (1452)
Grass and pollen (4)
Guidances (82)
Healthcare (4193)
HIV (7)
Huntington's disease (6)
IgA nephropathy (20)
Immunology and inflammation (44)
Immuno-oncology (2)
Indications (21)
Infectious disease (916)
Inflammatory bowel disease (65)
Inflation Reduction Act (7)
Influenza (19)
Intellectual property (69)
Interviews (59)
IPO (6779)
IRA (31)
Job creations (2135)
Job search strategy (380)
Kidney cancer (7)
Labor market (18)
Layoffs (192)
Leadership (4)
Legal (3792)
Liver cancer (32)
Longevity (6)
Lung cancer (137)
Lymphoma (82)
Machine learning (4)
Management (16)
Manufacturing (232)
MASH (45)
Medical device (2263)
Medtech (2266)
Mergers & acquisitions (10999)
Metabolic disorders (339)
Multiple sclerosis (34)
NASH (14)
Neurodegenerative disease (37)
Neuropsychiatric disorders (11)
Neuroscience (748)
NextGen: Class of 2025 (1699)
Non-profit (635)
Now hiring (11)
Obesity (186)
Opinion (130)
Ovarian cancer (27)
Pain (68)
Pancreatic cancer (35)
Parkinson's disease (61)
Partnered (7)
Patents (157)
Patient recruitment (56)
Peanut (12)
People (31113)
Pharmaceutical (64)
Pharmacy benefit managers (14)
Phase I (9036)
Phase II (14495)
Phase III (12713)
Pipeline (748)
Policy (98)
Postmarket research (1447)
Preclinical (3629)
Press Release (27)
Prostate cancer (68)
Psychedelics (10)
Radiopharmaceuticals (137)
Rare diseases (217)
Real estate (2913)
Recruiting (17)
Regulatory (11350)
Reports (16)
Research institute (605)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (4)
RSV (9)
Schizophrenia (48)
Series A (60)
Series B (31)
Service/supplier (4)
Sickle cell disease (35)
Special edition (6)
Spinal muscular atrophy (79)
Sponsored (7)
Startups (1854)
State (2)
Stomach cancer (4)
Supply chain (37)
Tariffs (43)
The Weekly (34)
Vaccines (197)
Venture capital (19)
Weight loss (103)
Women's health (11)
Worklife (4)
Date
Today (33)
Last 7 days (144)
Last 30 days (707)
Last 365 days (12404)
2025 (6845)
2024 (14064)
2023 (16100)
2022 (22800)
2021 (23374)
2020 (21936)
2019 (16683)
2018 (13051)
2017 (15468)
2016 (14650)
2015 (17260)
2014 (13928)
2013 (11943)
2012 (12848)
2011 (13344)
2010 (12125)
Location
Africa (340)
Alabama (18)
Alaska (1)
Arizona (62)
Arkansas (3)
Asia (31260)
Australia (4032)
California (2397)
Canada (1202)
China (435)
Colorado (89)
Connecticut (97)
Delaware (79)
Europe (46157)
Florida (434)
Georgia (49)
Hawaii (1)
Idaho (9)
Illinois (256)
India (20)
Indiana (164)
Iowa (1)
Japan (188)
Kansas (67)
Kentucky (16)
Louisiana (3)
Maine (5)
Maryland (374)
Massachusetts (2014)
Michigan (37)
Minnesota (136)
Mississippi (1)
Missouri (27)
Montana (8)
Nebraska (6)
Nevada (12)
New Hampshire (6)
New Jersey (1078)
New Mexico (7)
New York (751)
North Carolina (492)
North Dakota (2)
Northern California (974)
Ohio (57)
Oklahoma (4)
Oregon (17)
Pennsylvania (567)
Puerto Rico (9)
Rhode Island (10)
South America (555)
South Carolina (5)
Southern California (1033)
Tennessee (42)
Texas (327)
United States (9820)
Utah (57)
Virginia (106)
Washington D.C. (38)
Washington State (157)
West Virginia (1)
Wisconsin (23)
302,368 Results for "faron pharmaceuticals ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Faron Pharmaceuticals Ltd: Director/PCA Dealing
July 1, 2025
·
3 min read
Press Releases
Faron Pharmaceuticals Ltd: Grant of Options
May 15, 2025
·
5 min read
Press Releases
Faron’s Bexmarilimab Demonstrates Immune-Activating and Drug-Sensitizing Potential in Myeloid Malignancies
May 27, 2025
·
6 min read
Press Releases
Faron Pharmaceuticals presents updated Phase II data from BEXMAB Study at EHA 2025
June 12, 2025
·
6 min read
Press Releases
Faron Pharmaceuticals Presents Phase II Data from BEXMAB Study at ASCO 2025
June 2, 2025
·
7 min read
Press Releases
Faron Appoints Ralph Hughes as Chief Business Officer (CBO)
May 21, 2025
·
4 min read
Press Releases
Faron Announces Acceptance of Two Studies Involving Bexmarilimab, One of Them as an Oral Presentation, at the 19th International Congress of Immunology (IUIS) 2025
July 9, 2025
·
5 min read
Press Releases
Faron Pharmaceuticals Presents Promising Phase 1/2 Data from BEXMAB Study at MDS 2025 Plenary Session
May 12, 2025
·
7 min read
Press Releases
Faron Announces Publication of Full Phase I BEXMAB Study Data in Lancet Haematology
May 30, 2025
·
6 min read
Press Releases
Faron Announces Acceptance of Bexmarilimab Data for Oral Presentation at EHA 2025 Congress
May 15, 2025
·
4 min read
1 of 30,237
Next
